Fig. 5.
Survival curves for 145 patients with B-CLL.
From date of diagnosis, comparing patients whose cells are CD38+ with unmutated IgVH genes (, n = 34) with those whose cells are CD38− with mutatedIgVH genes (▴, n = 70) and those whose cells gave discordant results for the 2 assays (▪, n = 41).